BioNTech Could Supply 3 Billion Covid Shots in 2022: CEO

The CEO of Biotech discusses the company's production capabilities, partnerships, and future plans. They are evaluating production based on market needs and have established a network with 13 partners. The goal is to produce enough vaccines to meet global demand by the end of 2022, with plans to increase capacity to 3 billion doses if needed. The company is confident in meeting these targets, provided there are no major production issues.

What factor does the CEO of Biotech mention as influencing their ability to boost production?

• The location of production sites

• The availability of raw materials

• The company's order book

• The number of employees

How many partners does Biotech currently have in its production network?

• 10

• 13

• 15

• 20

Which company is mentioned as part of Biotech's production network?

• Moderna

• Pfizer

• Johnson & Johnson

• Novartis

By the end of 2022, how many vaccine doses does Biotech aim to produce?

• 4 billion

• 3 billion

• 2 billion

• 1 billion

What does the CEO say will influence the need to increase manufacturing capacity?

• Government regulations

• Demand and changes in virus strains

• Availability of funding

• Technological advancements